Ikarian Capital’s Alpine Immune Sciences Inc ALPN Stock Holding History

Ikarian Capital’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-103,000	Closed	-$4.08M	–	158
2024 Q1	$4.08M	Buy	+103,000	New	+$3.04M	0.45%	62

Ikarian Capital's ALPN Position: Q2 2024 in Review

Ikarian Capital sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 261,365 shares — an estimated $10.4M sold.

Ikarian Capital first reported a position in ALPN in Q4 2019 and held it in 8 quarters. The position peaked at $10.4M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Ikarian Capital reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Ikarian Capital sold 261,365 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $10.4M.
Ikarian Capital first reported a position in Alpine Immune Sciences Inc in Q4 2019 and held it in 8 quarters.
Ikarian Capital's Alpine Immune Sciences Inc position peaked at $10.4M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Ikarian Capital's 13F filing for Q2 2024, filed 14 Aug 2024.